Advertisement

Topics

GW cannabis-derived epilepsy drug gets positive FDA staff review

06:24 EDT 17 Apr 2018 | Reuters

LONDON (Reuters) - GW Pharmaceuticals' cannabis-derived medicine for severe childhood epilepsy won a favorable review from U.S. Food and Drug Administration (FDA) staff on Tuesday, boosting hopes for its approval in the world's biggest drugs market. ...

Original Article: GW cannabis-derived epilepsy drug gets positive FDA staff review

NEXT ARTICLE

More From BioPortfolio on "GW cannabis-derived epilepsy drug gets positive FDA staff review"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...